Leaflet CARDURA XL 4mg modified release tablets


Indicated for: hypertension; benign prostatic hyperplasia

Route of administration: oral

Substance: doxazosin (alpha-1 blocker)

ATC: C02CA04 (Cardiovascular system | Antiadrenergic agents, peripherally acting | Alpha-adrenoreceptor antagonists)

Doxazosin is an alpha-blocker used for the treatment of hypertension and symptoms of benign prostatic hyperplasia. It works by relaxing the smooth muscles in the walls of blood vessels and the prostate, improving blood flow and urinary flow.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to monitor blood pressure during treatment.

Side effects may include dizziness, headache, fatigue, or orthostatic hypotension. In rare cases, severe allergic reactions or priapism may occur.

Doxazosin is not recommended for patients with hypersensitivity to alpha-blockers or a history of severe hypotension.

CARDURA XL 4mg modified release tablets UPJOHN EESV, doxazosin

General data about CARDURA XL 4mg

  • Substance: doxazosin
  • Date of last drug list: 01-05-2026
  • Commercial code: W67252002
  • Concentration: 4mg
  • Pharmaceutical form: modified release tablets
  • Quantity: 28
  • Product type: original
  • Price: 32.16 RON
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: PFIZER MANUFACTURING DEUTSCHLAND GmbH - GERMANIA
  • Holder: UPJOHN EESV - OLANDA
  • Number: 1245/2008/02
  • Shelf life: 3 years

Concentrations available for doxazosin

  • 1mg
  • 2mg
  • 4mg

Combinations with other substances

Compensation lists for CARDURA XL 4mg Upjohn

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

32.16 RON

22.46 RON

9.70 RON

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

32.16 RON

22.46 RON

9.70 RON